SG11202001551YA - Dynamic human heavy chain antibody libraries - Google Patents
Dynamic human heavy chain antibody librariesInfo
- Publication number
- SG11202001551YA SG11202001551YA SG11202001551YA SG11202001551YA SG11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA
- Authority
- SG
- Singapore
- Prior art keywords
- heavy chain
- chain antibody
- human heavy
- antibody libraries
- dynamic human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/04—Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2017/098299 WO2019036842A1 (en) | 2017-08-21 | 2017-08-21 | DYNAMIC LIBRARIES OF HUMAN HEAVY CHAIN ANTIBODIES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202001551YA true SG11202001551YA (en) | 2020-03-30 |
Family
ID=65438261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202001551YA SG11202001551YA (en) | 2017-08-21 | 2017-08-21 | Dynamic human heavy chain antibody libraries |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11578426B2 (ja) |
| EP (1) | EP3673101A4 (ja) |
| JP (2) | JP2020537632A (ja) |
| KR (2) | KR20200038996A (ja) |
| CN (1) | CN111279024B (ja) |
| AU (1) | AU2017428737B2 (ja) |
| BR (1) | BR112020003622A2 (ja) |
| CA (1) | CA3072143A1 (ja) |
| IL (1) | IL272696B1 (ja) |
| SG (1) | SG11202001551YA (ja) |
| WO (1) | WO2019036842A1 (ja) |
| ZA (1) | ZA202001114B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111511762A (zh) | 2017-08-21 | 2020-08-07 | 天演药业公司 | 抗cd137分子及其用途 |
| US11585014B2 (en) | 2017-08-21 | 2023-02-21 | Adagene Inc. | Dynamic human antibody light chain libraries |
| WO2019148445A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
| WO2019148444A1 (en) | 2018-02-02 | 2019-08-08 | Adagene Inc. | Anti-ctla4 antibodies and methods of making and using the same |
| CN115956089A (zh) | 2020-05-04 | 2023-04-11 | 加利福尼亚大学董事会 | 抑制性抗enpp1抗体 |
| WO2023193239A1 (en) * | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| AU633698B2 (en) | 1990-01-12 | 1993-02-04 | Amgen Fremont Inc. | Generation of xenogeneic antibodies |
| DE4002897A1 (de) * | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US20030036092A1 (en) | 1991-11-15 | 2003-02-20 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
| US5866344A (en) | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク． | 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体 |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| ATE549918T1 (de) | 1996-12-03 | 2012-04-15 | Amgen Fremont Inc | Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| JP4171844B2 (ja) | 2001-11-22 | 2008-10-29 | 学校法人慶應義塾 | 超レパートリー人工抗体ライブラリー |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| CA2608058C (en) | 2005-05-12 | 2013-09-10 | Crucell Holland B.V. | Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| US8679490B2 (en) | 2005-11-07 | 2014-03-25 | Genentech, Inc. | Binding polypeptides with diversified and consensus VH/VL hypervariable sequences |
| PL2274008T3 (pl) | 2008-03-27 | 2014-07-31 | Zymogenetics Inc | Kompozycje i sposoby hamowania PDGFRbeta i VEGF-A |
| CA3117920A1 (en) | 2010-07-16 | 2012-01-19 | Adimab, Llc | Libraries comprising segmental pools, and methods for their preparation and use |
| JP5997154B2 (ja) | 2010-08-16 | 2016-09-28 | ノビミューン エスアー | 多重特異性多価抗体の生成方法 |
| US20160145604A1 (en) | 2013-03-14 | 2016-05-26 | Adagene Inc. | An Integrated System for Library Construction, Affinity Binder Screening and Expression Thereof |
| CN103603057B (zh) | 2013-07-03 | 2016-01-06 | 深圳大学 | 基于可感染病毒颗粒型抗体重链库/轻链库的抗体筛选和制备方法 |
| US20170306039A1 (en) * | 2014-10-22 | 2017-10-26 | Crescendo Biologics Limited | Human vh domain scaffolds |
| EP3350224B1 (en) | 2015-09-20 | 2024-06-19 | The United States of America, as Represented By the Secretary, Department of Health and Human Services | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (fgfr4) and methods of their use |
| US11585014B2 (en) | 2017-08-21 | 2023-02-21 | Adagene Inc. | Dynamic human antibody light chain libraries |
-
2017
- 2017-08-21 CN CN201780094151.XA patent/CN111279024B/zh active Active
- 2017-08-21 KR KR1020207007876A patent/KR20200038996A/ko not_active IP Right Cessation
- 2017-08-21 CA CA3072143A patent/CA3072143A1/en active Pending
- 2017-08-21 JP JP2020510115A patent/JP2020537632A/ja active Pending
- 2017-08-21 US US16/640,679 patent/US11578426B2/en active Active
- 2017-08-21 AU AU2017428737A patent/AU2017428737B2/en active Active
- 2017-08-21 EP EP17922682.4A patent/EP3673101A4/en active Pending
- 2017-08-21 BR BR112020003622-6A patent/BR112020003622A2/pt unknown
- 2017-08-21 KR KR1020247022149A patent/KR20240110891A/ko active Search and Examination
- 2017-08-21 IL IL272696A patent/IL272696B1/en unknown
- 2017-08-21 SG SG11202001551YA patent/SG11202001551YA/en unknown
- 2017-08-21 WO PCT/CN2017/098299 patent/WO2019036842A1/en unknown
-
2020
- 2020-02-21 ZA ZA2020/01114A patent/ZA202001114B/en unknown
-
2022
- 2022-11-10 JP JP2022180076A patent/JP2023025026A/ja not_active Withdrawn
-
2023
- 2023-01-11 US US18/153,070 patent/US20240240358A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111279024A (zh) | 2020-06-12 |
| KR20240110891A (ko) | 2024-07-16 |
| WO2019036842A1 (en) | 2019-02-28 |
| IL272696B1 (en) | 2024-09-01 |
| ZA202001114B (en) | 2024-06-26 |
| AU2017428737A8 (en) | 2020-03-12 |
| US20240240358A1 (en) | 2024-07-18 |
| AU2017428737B2 (en) | 2024-02-15 |
| CN111279024B (zh) | 2024-07-19 |
| EP3673101A4 (en) | 2021-03-24 |
| BR112020003622A2 (pt) | 2020-09-01 |
| KR20200038996A (ko) | 2020-04-14 |
| EP3673101A1 (en) | 2020-07-01 |
| CA3072143A1 (en) | 2019-02-28 |
| IL272696A (en) | 2020-04-30 |
| JP2020537632A (ja) | 2020-12-24 |
| US20200248336A1 (en) | 2020-08-06 |
| JP2023025026A (ja) | 2023-02-21 |
| AU2017428737A1 (en) | 2020-03-05 |
| US11578426B2 (en) | 2023-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267797A (en) | Anti-gpc3 antibody | |
| IL268517A (en) | Anti-tigit antibodies | |
| IL268620A (en) | Antibodies against LAG3 | |
| IL273411A (en) | Antibody against PD-L1 and its uses | |
| HUE067040T2 (hu) | Anti-SIRPalfa antitestek | |
| IL272696A (en) | Dynamic human heavy chain antibody libraries | |
| GB201709808D0 (en) | Antibodies | |
| IL268112A (en) | Anti-TGF-beta antibodies and their use | |
| SG11202004172UA (en) | Il2rbeta/common gamma chain antibodies | |
| SG10201913206RA (en) | Antibodies comprising modified heavy constant regions | |
| IL270698A (en) | Canine antibody libraries | |
| HUE059237T2 (hu) | GARP-TGF-béta antitestek | |
| IL272699A (en) | Dynamic human antibody light chain libraries | |
| IL314823A (en) | Combinations of ANTI-FOLR1 immunoconjugates and ANTI-PD-1 antibodies | |
| GB201720970D0 (en) | Antibodies | |
| IL273529A (en) | Anti-PACAP antibody | |
| IL271818A (en) | VH single chain and heavy chain antibodies | |
| IL271067A (en) | Anti-trkb antibodies | |
| IL272266A (en) | Anti-CD147 antibody | |
| PT3456736T (pt) | Variantes de anticorpos | |
| ZA202001830B (en) | Antibody variants | |
| IL272951A (en) | antibody variants | |
| GB201711785D0 (en) | Antibodies | |
| GB201709592D0 (en) | Antibody | |
| GB201717006D0 (en) | Anti-OPG antibodies |